arrow_back Back to App

Fentanyl Control Extension: New Rules for Substance Evaluation and Classification

This act extends temporary controls on fentanyl-related substances for two years. It introduces new procedures for the scientific and medical evaluation of these substances, which may lead to their removal from schedules or reclassification if found to have lower abuse potential. The act also requires notifying individuals accused or convicted of offenses involving a substance if its classification changes.
Key points
Temporary controls on fentanyl-related substances are extended for two years after the date of enactment.
The Attorney General must create synthetic compounds of encountered substances for scientific evaluation by the Secretary of Health and Human Services.
Substances may be removed from Schedule I or rescheduled to Schedule III, IV, or V based on evaluations of their abuse potential.
The Attorney General is required to notify individuals with pending prosecutions or convictions involving a substance that is subsequently removed or rescheduled.
$50 million is authorized for fiscal years 2023 and 2024 for the evaluation of fentanyl-related substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_5167
Sponsor: Sen. Booker, Cory A. [D-NJ]
Process start date: 2022-12-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

TEST Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_5167.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-12-01.

What are the main provisions?

Key points include:

  • Temporary controls on fentanyl-related substances are extended for two years after the date of enactment.
  • The Attorney General must create synthetic compounds of encountered substances for scientific evaluation by the Secretary of Health and Human Services.
  • Substances may be removed from Schedule I or rescheduled to Schedule III, IV, or V based on evaluations of their abuse potential.
  • The Attorney General is required to notify individuals with pending prosecutions or convictions involving a substance that is subsequently removed or rescheduled.
  • $50 million is authorized for fiscal years 2023 and 2024 for the evaluation of fentanyl-related substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Booker, Cory A. [D-NJ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health Courts and Law Security